Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,305 | 1,184 | 1,126 | 771 | 539 |
| Income taxes - deferred | -114 | -285 | -4,666 | 4,669 | -1,412 |
| Accounts receivable | 3,044 | -7,899 | 2,573 | 14,807 | -15,425 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | -3,947 |
| Other Working Capital | -2,522 | -3,619 | -10,270 | -5,227 | -26,835 |
| Other Operating Activity | -11,092 | 4,943 | -4,157 | -13,967 | 26,960 |
| Operating Cash Flow | $-9,379 | $-5,676 | $-15,394 | $1,053 | $-20,120 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | 0 | 0 | -2 | 0 | 0 |
| Other Investing Activity | -1,004 | -2,919 | -3,490 | -9,463 | -10,799 |
| Investing Cash Flow | $-1,004 | $-2,919 | $-3,492 | $-9,463 | $-10,799 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 18,111 | N/A | N/A | N/A | N/A |
| Debt Repayment | -895 | -4,114 | -341 | -6,153 | N/A |
| Common Stock Issued | 0 | N/A | N/A | 188 | -189 |
| Other Financing Activity | 1,679 | 19,289 | 1,966 | 10,935 | 407 |
| Financing Cash Flow | $18,895 | $15,175 | $1,625 | $4,970 | $218 |
| Exchange Rate Effect | N/A | N/A | N/A | -49 | 94 |
| Beginning Cash Position | 27,946 | 21,366 | 38,627 | 42,116 | 72,723 |
| End Cash Position | 36,458 | 27,946 | 21,366 | 38,627 | 42,116 |
| Net Cash Flow | $8,512 | $6,580 | $-17,261 | $-3,440 | $-30,701 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,379 | -5,676 | -15,394 | 1,053 | -20,120 |
| Capital Expenditure | -1,004 | -2,919 | -3,490 | -9,463 | -10,799 |
| Free Cash Flow | -10,383 | -8,595 | -18,884 | -8,410 | -30,919 |